C61 is a billable/specific diagnosis code from the 2026 ICD-10-CM used to classify the following condition: Malignant neoplasm of prostate.
Use additional code
Code, if applicable, to identify:
Hormone sensitivity status (Z19.1-Z19.2)
Rising PSA following treatment for malignant neoplasm of prostate (R97.21)
Type 1 excludes
Malignant neoplasm of seminal vesicle (C63.7)
Versions
2026
No changes
2025
No changes
2024
No changes
2023
Code changed
Use additional code
code to identify:hormone sensitivity status (Z19.1-Z19.2)rising PSA following treatment for malignant neoplasm of prostate (R97.21)
- code, if applicable, to identify:
- hormone sensitivity status (Z19.1-Z19.2)
- rising PSA following treatment for malignant neoplasm of prostate (R97.21)
2022
No changes
2021
No changes
2020
No changes
2019
No changes
2018
No changes
2017
Code changed
Use additional code
- code to identify:
- hormone sensitivity status (Z19.1-Z19.2)
- rising PSA following treatment for malignant neoplasm of prostate (R97.21)
2016
New code